Applied Therapeutics, Inc.
APLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $79 | $50 | $17 | $54 |
| Short-Term Investments | $0 | $0 | $14 | $27 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $3 | $0 | $0 |
| Other Curr. Assets | $4 | $1 | $6 | $8 |
| Total Curr. Assets | $84 | $54 | $37 | $88 |
| Property Plant & Equip (Net) | $3 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $0 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $87 | $55 | $38 | $90 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $5 | $9 |
| Short-Term Debt | $0 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1 | $0 | $0 |
| Other Curr. Liab. | $22 | $68 | $28 | $16 |
| Total Curr. Liab. | $27 | $71 | $33 | $26 |
| LT Debt | $2 | $0 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $0 | $0 |
| Total NC Liab. | $2 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $0 | $1 | $1 |
| Total Liabilities | $30 | $72 | $34 | $27 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$574 | -$469 | -$349 | -$266 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $631 | $451 | $353 | $329 |
| Total Equity | $57 | -$17 | $4 | $63 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $87 | $55 | $38 | $90 |
| Net Debt | -$77 | -$49 | -$15 | -$52 |